TransMedics (TMDX) Revenue Growth (1y) (2019 - 2026)
TransMedics (TMDX) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 7.30% |
| 10 | TransMedics | 3.22 Bn | 2.75 Bn | 113.20 Mn | 20.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.70% |
| Mar 31, 2026 | 21.18% |
| Dec 31, 2025 | 32.18% |
| Sep 30, 2025 | 32.24% |
| Jun 30, 2025 | 37.68% |
| Mar 31, 2025 | 48.21% |
| Dec 31, 2024 | 49.83% |
| Sep 30, 2024 | 63.72% |
| Jun 30, 2024 | 117.87% |
| Mar 31, 2024 | 133.07% |
| Dec 31, 2023 | 158.72% |
| Sep 30, 2023 | 158.65% |
| Jun 30, 2023 | 155.66% |
| Mar 31, 2023 | 161.68% |
| Dec 31, 2022 | 267.17% |
| Sep 30, 2022 | 378.27% |
| Jun 30, 2022 | 136.77% |
| Mar 31, 2022 | 107.94% |
| Dec 31, 2021 | 12.04% |
| Sep 30, 2021 | -32.65% |